Literature DB >> 35607990

Cerebrovascular reactivity and deep white matter hyperintensities in migraine: A prospective CO2 targeting study.

Mi Ji Lee1,2, Bo-Yong Park3, Soohyun Cho4, Seonwoo Kim5, Hyunjin Park6,7, Sung Tae Kim8, Chin-Sang Chung9.   

Abstract

Several studies suggested the association of migraine with deep white matter hyperintensities (WMHs). We aimed to explore the cerebrovascular reactivity (CVR), deep WMH burden, and their association in patients with migraine using a state-of-the-art methodology. A total of 31 patients with migraine without aura and 31 age/sex-matched controls underwent 3T MRI with prospective end-tidal carbon dioxide (CO2) targeting. We quantified deep WMH clusters using an automated segmentation tool and measured voxel-wise CVR by changes in blood oxygen level-dependent signal fitted to subjects' end-tidal CO2. The association of migraine and CVR with the presence of WMH in each voxel and interaction of migraine and CVR on WMH were analysed. Patients had a higher number of deep WMHs than controls (p = 0.015). Migraine and reduced CVR were associated with increased probability of having WMHs in each voxel (adjusted OR 30.78 [95% CI 1.89-500.53], p = 0.016 and adjusted OR 0.30 [0.29-0.32], p < 0.001, respectively). Migraine had an effect modification on CVR on deep WMHs (p for interaction <0.001): i.e. the association between CVR and WMH was greater in patients than in controls. We suggest that the migraine-WMH association can be explained by the effect modification on the CVR.

Entities:  

Keywords:  Migraine; cerebrovascular reactivity; endothelial function; vasomotor reactivity; white matter hyperintensity

Mesh:

Substances:

Year:  2022        PMID: 35607990      PMCID: PMC9536123          DOI: 10.1177/0271678X221103006

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.960


  56 in total

1.  Cortical glutamate in migraine.

Authors:  Ronald Zielman; Jannie P Wijnen; Andrew Webb; Gerrit L J Onderwater; Itamar Ronen; Michel D Ferrari; Hermien E Kan; Gisela M Terwindt; Mark C Kruit
Journal:  Brain       Date:  2017-07-01       Impact factor: 13.501

2.  Cerebrovascular reactivity in the brain white matter: magnitude, temporal characteristics, and age effects.

Authors:  Binu P Thomas; Peiying Liu; Denise C Park; Matthias J P van Osch; Hanzhang Lu
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-06       Impact factor: 6.200

3.  AFNI: software for analysis and visualization of functional magnetic resonance neuroimages.

Authors:  R W Cox
Journal:  Comput Biomed Res       Date:  1996-06

4.  Systemic and cerebral endothelial dysfunction in chronic migraine. A case-control study with an active comparator.

Authors:  Vicente González-Quintanilla; María Toriello; Enrique Palacio; Miguel A González-Gay; Jesús Castillo; Silvia Montes; Rosa Martínez-Nieto; Jenifer Fernandez; Alvaro Rojo; Silvia Gutiérrez; Enar Pons; Agustín Oterino
Journal:  Cephalalgia       Date:  2015-09-22       Impact factor: 6.292

5.  Reproducibility of cerebrovascular reactivity measures in children using BOLD MRI.

Authors:  Jackie Leung; Junseok A Kim; Andrea Kassner
Journal:  J Magn Reson Imaging       Date:  2015-10-05       Impact factor: 4.813

6.  Cerebrovascular reactivity as a determinant of deep white matter hyperintensities in migraine.

Authors:  Mi Ji Lee; Bo-Yong Park; Soohyun Cho; Hyunjin Park; Chin-Sang Chung
Journal:  Neurology       Date:  2019-01-04       Impact factor: 9.910

7.  Comparing cerebrovascular reactivity measured using BOLD and cerebral blood flow MRI: The effect of basal vascular tension on vasodilatory and vasoconstrictive reactivity.

Authors:  Sheliza Halani; Jonathan B Kwinta; Ali M Golestani; Yasha B Khatamian; J Jean Chen
Journal:  Neuroimage       Date:  2015-02-03       Impact factor: 6.556

8.  Exaggerated interictal cerebrovascular reactivity but normal blood flow velocities in migraine without aura.

Authors:  B Dora; S Balkan
Journal:  Cephalalgia       Date:  2002-05       Impact factor: 6.292

9.  Structural brain changes in migraine.

Authors:  Inge H Palm-Meinders; Hille Koppen; Gisela M Terwindt; Lenore J Launer; Junya Konishi; Juliette M E Moonen; Jacobus T N Bakkers; Paul A M Hofman; Baldur van Lew; Huub A M Middelkoop; Mark A van Buchem; Michel D Ferrari; Mark C Kruit
Journal:  JAMA       Date:  2012-11-14       Impact factor: 56.272

10.  Migraine as a risk factor for subclinical brain lesions.

Authors:  Mark C Kruit; Mark A van Buchem; Paul A M Hofman; Jacobus T N Bakkers; Gisela M Terwindt; Michel D Ferrari; Lenore J Launer
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.